[go: up one dir, main page]

Tempfer et al., 2000 - Google Patents

Endothelial Nitric Oxide Synthase Gene Polymorphism in Women with Idiopathic Recurrent Miscarriage

Tempfer et al., 2000

View PDF
Document ID
2695749084075260754
Author
Tempfer C
Unfried G
Nagele F
Huber J
Publication year
Publication venue
Fertility and Sterility

External Links

Snippet

Objective: Lack of endothelium-derived nitric oxide is associated with vasospasm and vascular infarction. We investigated the relation between idiopathic recurrent miscarriage before 20 weeks gestation and an intron 4 polymorphism of the gene encoding endothelial …
Continue reading at www.fertstert.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6879—Hybridisation probes for sex determination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—"In-situ" hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Tejera et al. Successful pregnancy and childbirth after intracytoplasmic sperm injection with calcium ionophore oocyte activation in a globozoospermic patient
Kang et al. Preimplantation genetic screening: who benefits?
Frattarelli et al. Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles
Sakkas et al. Early cleavage of human embryos to the two-cell stage after intracytoplasmic sperm injection as an indicator of embryo viability.
US20090163764A1 (en) Methods of determining human egg competency
Cobo et al. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis
Kahraman et al. The results of aneuploidy screening in 276 couples undergoing assisted reproductive techniques
Check et al. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve
Benkhalifa et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study
Fang et al. Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained
Banks et al. Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome?
Grimbizis et al. Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers.
Rosen et al. Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation
Pehlivan et al. Preimplantation Genetic Diagnosis by Fluorescence In Situ Hybridiation: Clinical Possibliities and Pitfalls
Tempfer et al. Endothelial Nitric Oxide Synthase Gene Polymorphism in Women with Idiopathic Recurrent Miscarriage
Fishel et al. Reproductive possibilities for infertile
Kim et al. The evidence of follicle maturation and subsequent ovulation in human ovarian tissue xenografted into severe combined immunodeficient (SCID) mice
Porcu et al. Four healthy children from frozen human oocytes and frozen human sperms.
Vendrell et al. Spermatogenic patterns and early embryo development after intracytoplasmic sperm injection in severe oligoasthenozoospermia
Wasfi et al. Evaluation of Various Non-Invasive Investigative Procedures for Etiological Differentiation Between Obstructive and Non-Obstructive Azoospermia
Niu et al. It Is Worthwhile to Cryopreserve Metaphase I Oocytes for Patients With Oocytes Cryopreservation: A Live Birth Case Report
Yoshizawa Chromosomal abnormalities and embryonic development into the blastocyst stage in mammalian embryos derived in vitro
Mourad et al. GROWTH HORMONE IS USELESS IN IVF: THE LARGEST RANDOMIZED CONTROLLED TRIAL
Reichman et al. Recurrent implantation failure
Zhang et al. Preimplantation genetic testing for aneuploidy failed to improve cumulative live birth rate in patients with limited good-quality embryos: a retrospective cohort study